Get early visibility on spin-outs emerging from UK research

Join the Innovate UK ICURe investor waitlist to receive curated updates on innovation-led ventures, showcase invites and insights from the UK’s spin-out pipeline.

Innovate UK ICURe has supported over 360 spin-outs from leading UK research institutions - raising more than £1.55 billion in follow-on investment.

We’re now inviting investors to join our waitlist for early insight into ventures preparing to spin out and raise at pre-seed and seed stage.

Register your interest to receive curated updates, showcase invitations and insights into new spin-outs from across the UK research base.

Discover spin-outs early

Gain visibility into ICURe teams before they raise. Our updates give you insight into upcoming spin-outs across AI, life sciences, deep tech, sustainability and more.

Avoid missing high-potential opportunities

Innovate UK ICURe updates help you stay ahead of emerging innovation, without the noise. No introductions or recommendations, just visibility on what’s coming next.

Why early access matters

ICURe spin-outs are born from world-class UK research. Early awareness means you can assess potential opportunities at the right time — from pre-spin-out to early traction.

About Innovate UK ICURe

The Innovate UK ICURe Programme helps researchers turn breakthrough innovations into investment-ready spin-outs and licensing opportunities.

We provide funding and tailored support to test the commercial potential of research ideas — enabling academics to take their first steps into business.

Since 2014, ICURe has supported over 360 spin-outs, resulting in more than £1.55 billion in follow-on investment.

ICURe is the UK’s leading pre-accelerator for research commercialisation, working with universities, PSREs and research institutions across the UK.

Join the waitlist and gain early access to new spin-outs.

When you sign up, you’ll receive:

  • Investor updates on spin-outs preparing to raise

  • Invitations to showcases and insight events

  • Early access to the pipeline of ventures emerging from the UK research base

Be among the first to see what’s coming next — across AI, deep tech, life sciences and more.